China Approves SinoVac's CoronaVac, As 50.6% Efficacy Reported

Slow Roll-Out Despite Looming New Year Holiday

 
• By Brian Yang
  
New Vaccine for Coronavirus COVID 19. Concept Medical container with Corona Virus Vaccines. Korona Vaccination Medical Syringe needle Outbreak. Usa, China, Italy
SINOVAC'S CORONAVAC GAINS CHINA APPROVAL WITH 50.6% EFFICACY • Source: Shutterstock

More from China

More from Focus On Asia